08/27/2024
3:30 PM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/09/2024
3:35 PM | Eagle Pharmaceuticals (Filer)
| Form NT 10-Q | |
08/05/2024
8:03 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/10/2024
7:00 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/08/2024
3:32 PM | BlackRock Inc. (Filed by)
Eagle Pharmaceuticals (Subject)
| Form SC 13G/A | |
07/03/2024
1:02 PM | Eagle Pharmaceuticals (Subject)
Nantahala Capital Management, LLC (Filed by)
| Form SC 13G | |
05/29/2024
7:20 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
05/22/2024
8:08 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2024
8:29 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/10/2024
4:27 PM | Eagle Pharmaceuticals (Filer)
| Form NT 10-Q | |
04/12/2024
3:16 PM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/12/2024
3:16 PM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/18/2024
7:37 PM | Eagle Pharmaceuticals (Subject)
Tarriff Scott (Filed by)
| Form SC 13G/A | |
03/18/2024
7:00 AM | Eagle Pharmaceuticals (Filer)
| Form NT 10-K | |
03/08/2024
3:49 PM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/01/2024
3:40 PM | Eagle Pharmaceuticals (Issuer)
Tarriff Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
6:35 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/29/2024
7:23 PM | Cahill Brian Joseph (Reporting)
Eagle Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
3:44 PM | Eagle Pharmaceuticals (Issuer)
Tarriff Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
7:09 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/13/2024
2:53 PM | Eagle Pharmaceuticals (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
| Form SC 13G/A | |
02/13/2024
7:50 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/12/2024
12:38 PM | BRANDES INVESTMENT PARTNERS, LP (Filed by)
Eagle Pharmaceuticals (Subject)
| Form SC 13G | |
02/07/2024
8:15 AM | Eagle Pharmaceuticals (Subject)
HIRSCHMAN ORIN (Filed by)
| Form SC 13G | |
02/06/2024
4:09 PM | Cahill Brian Joseph (Reporting)
Eagle Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2024
1:04 PM | Eagle Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/18/2024
5:56 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/16/2024
6:00 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/09/2024
4:00 PM | Eagle Pharmaceuticals (Issuer)
Tarriff Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2024
4:01 PM | Cahill Brian Joseph (Reporting)
Eagle Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/22/2023
6:00 PM | Eagle Pharmaceuticals (Issuer)
Graves Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/22/2023
4:15 PM | Eagle Pharmaceuticals (Filer)
| Form 8-K/A | |
12/20/2023
3:34 PM | Cahill Brian Joseph (Reporting)
Eagle Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/15/2023
4:11 PM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/06/2023
3:26 PM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/29/2023
6:36 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/29/2023
6:39 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/09/2023
4:23 PM | Eagle Pharmaceuticals (Filer)
| Form NT 10-Q | |
11/09/2023
6:57 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/03/2023
3:39 PM | Eagle Pharmaceuticals (Issuer)
Tarriff Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/31/2023
4:41 PM | Eagle Pharmaceuticals (Issuer)
Graves Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Tim Sykes’ Urgent Trade Alert: “Make this move now” (Ad) WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock
This $2 trillion D.C. shock is NOT about Trump or Biden dropping out of the race… Click here to see a unique election-year trade |
10/24/2023
7:49 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/23/2023
6:10 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/04/2023
4:07 PM | Eagle Pharmaceuticals (Issuer)
Tarriff Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2023
3:48 PM | Eagle Pharmaceuticals (Subject)
Tarriff Scott (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/27/2023
6:00 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/07/2023
6:20 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
